Published in Eur Neuropsychopharmacol on March 15, 2010
Smoking status as a potential confounder in the study of brain structure in schizophrenia. J Psychiatr Res (2013) 0.92
Bilateral fronto-parietal integrity in young chronic cigarette smokers: a diffusion tensor imaging study. PLoS One (2011) 0.88
The cerebellum link to neuroticism: a volumetric MRI association study in healthy volunteers. PLoS One (2012) 0.83
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review. Curr Neuropharmacol (2015) 0.79
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. J Psychiatry Neurosci (2015) 0.77
Peripapillary retinal nerve fiber layer thickness in bipolar disorder. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Effect of tobacco smoking on frontal cortical thickness development: A longitudinal study in a mixed cohort of ADHD-affected and -unaffected youth. Eur Neuropsychopharmacol (2017) 0.75
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Small-world and scale-free organization of voxel-based resting-state functional connectivity in the human brain. Neuroimage (2008) 4.08
Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry (1999) 3.69
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44
Quantitative genetic modeling of variation in human brain morphology. Cereb Cortex (2001) 2.24
The association between brain volume and intelligence is of genetic origin. Nat Neurosci (2002) 2.21
Anatomical MRI of the developing human brain: what have we learned? J Am Acad Child Adolesc Psychiatry (2001) 1.92
Acute dystonia induced by drug treatment. BMJ (1999) 1.71
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Catatonia: disappeared or under-diagnosed? Psychopathology (2005) 1.64
Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci (2001) 1.60
Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry (2000) 1.55
Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. Am J Psychiatry (1998) 1.55
Multivariate genetic analysis of brain structure in an extended twin design. Behav Genet (2000) 1.49
Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry (2005) 1.49
Outcome of schizophrenia in relation to brain abnormalities. Schizophr Bull (1999) 1.46
Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand (2000) 1.45
Language lateralization in schizophrenia, an fMRI study. Schizophr Res (2001) 1.41
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry (1991) 1.41
An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol Psychiatry (2007) 1.38
Fluoxetine treatment of slow eating. J Clin Psychiatry (1992) 1.37
Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage (2007) 1.36
Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage (2000) 1.32
Schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence. Psychol Med (1997) 1.31
Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry (2001) 1.27
Health care reform and the special needs of children. Pediatrics (1994) 1.25
Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry (2006) 1.23
Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res (2002) 1.23
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry (2006) 1.23
Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord (1987) 1.22
[A bifid uvula in a patient with schizophrenia as a sign of 22q11 deletion syndrome]. Ned Tijdschr Geneeskd (2002) 1.22
Prenatal exposure to famine and brain morphology in schizophrenia. Am J Psychiatry (2000) 1.19
Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 1.19
Sex steroids and brain structure in pubertal boys and girls: a mini-review of neuroimaging studies. Neuroscience (2011) 1.19
Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neurosci Biobehav Rev (2011) 1.18
New perspectives in the diagnosis of hepatitis C. Semin Liver Dis (1999) 1.18
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand (2012) 1.17
Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage (2004) 1.14
Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry (1999) 1.14
Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychol Med (2005) 1.14
Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry (2001) 1.14
Contribution of residential exposures to asthma in us children and adolescents. Pediatrics (2001) 1.14
Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int J Epidemiol (2007) 1.13
Childhood trauma and auditory verbal hallucinations. Psychol Med (2012) 1.11
Normal fusion for three-dimensional integrated visualization of SPECT and magnetic resonance brain images. J Nucl Med (1997) 1.07
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res (1993) 1.07
Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res (2006) 1.07
Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects. Neuroimage (2001) 1.07
Tardive dystonia. Schizophr Bull (1999) 1.07
The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology (2000) 1.05
Language lateralization in monozygotic twin pairs concordant and discordant for handedness. Brain (2002) 1.05
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol (2007) 1.03
Language lateralization in female patients with schizophrenia: an fMRI study. Schizophr Res (2003) 1.01
The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. Schizophr Res (1996) 1.01
Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) (2000) 1.00
The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav (2007) 0.99
Statistical sulcal shape comparisons: application to the detection of genetic encoding of the central sulcus shape. Neuroimage (2000) 0.99
Microstructural alterations of the arcuate fasciculus in schizophrenia patients with frequent auditory verbal hallucinations. Schizophr Res (2011) 0.99
Psychosis and brain volume changes during the first five years of schizophrenia. Eur Neuropsychopharmacol (2008) 0.99
Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry (2004) 0.98
White matter development in early puberty: a longitudinal volumetric and diffusion tensor imaging twin study. PLoS One (2012) 0.97
Maternal depression, child behavior, and injury. Inj Prev (2007) 0.97
Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry (1998) 0.96
Genetic influences on thinning of the cerebral cortex during development. Neuroimage (2011) 0.96
Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res (1998) 0.96
The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl) (1998) 0.96
Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways. Mol Psychiatry (2009) 0.95
A double hit implicates DIAPH3 as an autism risk gene. Mol Psychiatry (2010) 0.95
Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. Br J Psychiatry Suppl (2002) 0.94
Can fMRI-guidance improve the efficacy of rTMS treatment for auditory verbal hallucinations? Schizophr Res (2007) 0.94
A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophr Res (2012) 0.93